ATE482398T1 - Verfahren zur stratifizierung von herzinsuffizienz - Google Patents
Verfahren zur stratifizierung von herzinsuffizienzInfo
- Publication number
- ATE482398T1 ATE482398T1 AT06754992T AT06754992T ATE482398T1 AT E482398 T1 ATE482398 T1 AT E482398T1 AT 06754992 T AT06754992 T AT 06754992T AT 06754992 T AT06754992 T AT 06754992T AT E482398 T1 ATE482398 T1 AT E482398T1
- Authority
- AT
- Austria
- Prior art keywords
- heart failure
- stratification
- preprobnp
- devices
- amount
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05010043A EP1722232A1 (de) | 2005-05-09 | 2005-05-09 | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
| PCT/EP2006/062031 WO2006120152A1 (en) | 2005-05-09 | 2006-05-03 | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE482398T1 true ATE482398T1 (de) | 2010-10-15 |
Family
ID=34936290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06754992T ATE482398T1 (de) | 2005-05-09 | 2006-05-03 | Verfahren zur stratifizierung von herzinsuffizienz |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110104813A1 (de) |
| EP (2) | EP1722232A1 (de) |
| JP (1) | JP4927825B2 (de) |
| CN (2) | CN103091497A (de) |
| AT (1) | ATE482398T1 (de) |
| CA (1) | CA2605247A1 (de) |
| DE (1) | DE602006017058D1 (de) |
| ES (1) | ES2352351T3 (de) |
| HK (1) | HK1119771A1 (de) |
| WO (1) | WO2006120152A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1722232A1 (de) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
| CA2671298C (en) | 2007-01-25 | 2020-07-28 | F. Hoffmann-La Roche Ag | Use of igfbp-7 in the assessment of heart failure |
| DK2425016T3 (en) | 2009-04-29 | 2015-06-29 | Amc Amsterdam | MEANS AND METHODS TO REMEDY THE, PREVENT AND / OR diagnose heart failure or EN risk of cardiac failure |
| EP2646822B1 (de) * | 2010-11-29 | 2017-11-01 | Alere San Diego, Inc. | Verfahren zur diagnose und risikovorhersage bei herzversagen |
| HUE042708T2 (hu) | 2012-08-09 | 2019-07-29 | Inst Nat Sante Rech Med | Szívelégtelenség diagnosztika |
| CN106716135B (zh) * | 2014-10-10 | 2019-03-15 | 松森昭 | 用于检测心力衰竭的装置及储存介质 |
| EP3464339A4 (de) * | 2016-06-03 | 2019-12-25 | Cedars-Sinai Medical Center | Proteolytischer test von b-typ-natriuretischem peptid zur beurteilung des risikos von herz-kreislauf-erkrankungen |
| US11193947B2 (en) | 2016-06-03 | 2021-12-07 | Cedars-Sinai Medical Center | B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment |
| WO2018030252A1 (ja) * | 2016-08-09 | 2018-02-15 | 大塚製薬株式会社 | 尿バイオマーカーを用いたアルツハイマー病の診断補助方法 |
| AU2018315056B2 (en) * | 2017-08-08 | 2021-06-17 | Queensland University Of Technology | Methods for diagnosis of early stage heart failure |
| US11255844B2 (en) * | 2018-03-06 | 2022-02-22 | Fresenius Medical Care Holdings, Inc. | Peritoneal dialysis systems and related methods |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| JP2676114B2 (ja) * | 1990-04-16 | 1997-11-12 | 塩野義製薬株式会社 | ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法 |
| PL204235B1 (pl) * | 1999-01-29 | 2009-12-31 | Roche Diagnostics Gmbh | Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych |
| US7632647B2 (en) * | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| AUPS169202A0 (en) * | 2002-04-11 | 2002-05-16 | Goetze, Jens Peter | Neuropeptide assay |
| MXPA03004105A (es) * | 2002-05-14 | 2004-10-15 | Hoffmann La Roche | Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores. |
| GB0216191D0 (en) * | 2002-07-11 | 2002-08-21 | Univ Leicester | Plasma urotensin in human heart failure |
| US8263325B2 (en) * | 2002-11-15 | 2012-09-11 | Ottawa Heart Institute Research Corporation | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis |
| US7109023B2 (en) * | 2002-11-18 | 2006-09-19 | Princeton Biomeditech Corporation | Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients |
| WO2004046729A2 (en) * | 2002-11-21 | 2004-06-03 | The University Of Leicester | Bodily fluid markers of tissue hypoxia |
| US7092759B2 (en) * | 2003-07-30 | 2006-08-15 | Medtronic, Inc. | Method of optimizing cardiac resynchronization therapy using sensor signals of septal wall motion |
| US7887750B2 (en) * | 2004-05-05 | 2011-02-15 | Bayer Healthcare Llc | Analytical systems, devices, and cartridges therefor |
| EP1722232A1 (de) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
-
2005
- 2005-05-09 EP EP05010043A patent/EP1722232A1/de not_active Withdrawn
-
2006
- 2006-05-03 CN CN2013100056784A patent/CN103091497A/zh active Pending
- 2006-05-03 EP EP06754992A patent/EP1880221B1/de active Active
- 2006-05-03 CN CN2006800158682A patent/CN101171517B/zh active Active
- 2006-05-03 CA CA002605247A patent/CA2605247A1/en not_active Abandoned
- 2006-05-03 AT AT06754992T patent/ATE482398T1/de active
- 2006-05-03 DE DE602006017058T patent/DE602006017058D1/de active Active
- 2006-05-03 ES ES06754992T patent/ES2352351T3/es active Active
- 2006-05-03 WO PCT/EP2006/062031 patent/WO2006120152A1/en not_active Application Discontinuation
- 2006-05-03 JP JP2008510547A patent/JP4927825B2/ja active Active
-
2007
- 2007-11-07 US US11/936,169 patent/US20110104813A1/en not_active Abandoned
-
2008
- 2008-10-17 HK HK08111542.2A patent/HK1119771A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006017058D1 (de) | 2010-11-04 |
| US20110104813A1 (en) | 2011-05-05 |
| CN103091497A (zh) | 2013-05-08 |
| CA2605247A1 (en) | 2006-11-16 |
| JP2008541078A (ja) | 2008-11-20 |
| CN101171517B (zh) | 2013-10-09 |
| EP1880221A1 (de) | 2008-01-23 |
| WO2006120152A1 (en) | 2006-11-16 |
| CN101171517A (zh) | 2008-04-30 |
| JP4927825B2 (ja) | 2012-05-09 |
| HK1119771A1 (en) | 2009-03-13 |
| ES2352351T3 (es) | 2011-02-17 |
| EP1722232A1 (de) | 2006-11-15 |
| EP1880221B1 (de) | 2010-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE482398T1 (de) | Verfahren zur stratifizierung von herzinsuffizienz | |
| HK1136627A1 (zh) | 根據 評價心臟介入風險的工具與方法 | |
| BRPI0410261A (pt) | método de detecção de probnp natural | |
| ATE415662T1 (de) | Bestimmung der tatsächlichen zeit, die ein prozessor bei der ausführung eines codeteiles aufwendet | |
| ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
| ATE514950T1 (de) | Verfahren zur untersuchung von sepsis bei menschen | |
| DE602006016589D1 (de) | Neue markierungsstrategien für den empfindlichen nachweis von analyten | |
| DE602005024639D1 (de) | Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern | |
| DK2341344T3 (da) | Fremgangsmåde til diagnosticering af en polycystisk nyresygdom | |
| ATE550354T1 (de) | Humane ringspezifische bnp-antikörper | |
| WO2010025393A3 (en) | Protein biomarkers and methods for diagnosing kawasaki disease | |
| DE602006006855D1 (de) | Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb) | |
| WO2007111938A3 (en) | Inflammation-inhibitory serum factors and uses thereof | |
| DE602006014798D1 (de) | Vorrichtung und Verfahren zur Unterscheidung zwischen akuter und chronischer Myokardial-Nekrose bei symptomatischen Patienten | |
| ATE524561T1 (de) | Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken | |
| ATE504002T1 (de) | Erkennung und vorhersage von frühgeburten | |
| ATE519116T1 (de) | Verfahren zur normierung der konzentration von analyten in einer urinprobe | |
| WO2007134028A3 (en) | Biomarkers for depression and methods using the same | |
| ATE473448T1 (de) | Verfahren zur diagnose von herz-kreislauf- krankheiten | |
| ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
| ATE488772T1 (de) | Biomarker zur beurteilung der leberfunktion | |
| DE112006000481A5 (de) | Verfahren zur Bestimmung der elastischen Verformung von Bauteilen | |
| ATE456797T1 (de) | Verwendung von nogo-c bei der beurteilung von herzversagen | |
| ATE437182T1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
| DE60126991D1 (de) | Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1880221 Country of ref document: EP |